- U.S. stocks experienced a decline on Monday, while several individual equities recorded significant gains.
- Kodiak Sciences surged 174 % to $88.79 following positive Phase 3 trial data for its wAMD treatments.
- Other notable movers included Chaince Digital Holdings, AMC Entertainment, and Agenus, driven by corporate actions and positive analyst coverage.